你即將離開本站

並前往https://www.pharmashots.com/21914/boehringer-ingelheim-reports-results-of-ofev-nintedanib-in-p-iii-inbuild-trial-for-patients-with-chronic-fibrosing-interstitial-lung-disease-with-progressive-phenotype-1

Boehringer Ingelheim Reports Results of OFEV (nintedanib) in ...

The P-III INBUILD trial involves assessing of OFEV vs PBO in patients with chronic fibrosing interstitial lung disease (ILDs) with signs of progression for 52 ...

確定！ 回上一頁

查詢 「INBUILD trial」的人也找了：

  1. INBUILD trial
    2.
  2. SENSCIS trial
    3.
  3. Nintedanib clinical trial
    4.
  4. pf-ild definition
    5.
  5. Pirfenidone
    6.
  6. TOMORROW trial
    7.
  7. RELIEF pirfenidone
    8.
  8. Progressive fibrosing interstitial lung disease
    9.